ArticleFrontiers in bioengineering and biotechnology2026
Evolution of the Canadian regulatory system for plant biotechnology.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canada was one of the first countries to adopt agricultural biotechnology products. This has served Canada well as it is constantly ranked among the world's top agriculture commodities exporters with its products reaching markets in all continents. However, the speed at which regulations enabling the commercialization and adoption of the latest agricultural biotechnologies did not match the pace with advancements in the field. As the years went by, a lack of clarity about regulatory interpretation created an unlevel playing field for Canadian plant breeders and companies. This started to change in 2022 when new policy changes were announced by the Canadian government, paving the way for the adoption of the latest technologies. The aim of this document is to bring together the key pieces of legislation and policy elements governing plant breeding innovations in Canada into a single consolidated reference. The paper reflects perspectives and interpretations by Canadian industry regulatory experts on the 38-year history and evolution of the regulatory landscape in Canada to support clarity and consistent application for future developers and innovators in this sector.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.